Interneuron defects are a common feature of monogenic epilepsies.
Major modifiable targets include migration, differentiation, and excitability.
Early intervention gene models include Arx, Dcx, Lis1, Tsc1, Pten, Kcna1, and Scn1a.
Brain developmental programs offer effective therapeutic targets for disease modification.